Exploring the Therapeutic Potentials of Exopolysaccharides Derived From Lactic Acid Bacteria and Bifidobacteria: Antioxidant, Antitumor, and Periodontal Regeneration
The metabolites of lactic acid bacteria (LAB) and bifidobacteria (Bb) have recently received a lot of attention due to their ability to protect interactions in blood and tissues, as well as their biodegradability and biocompatibility in human tissue. Exopolysaccharides (EPS) derived from bacteria ha...
Saved in:
Published in | Frontiers in microbiology Vol. 13; p. 803688 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
25.04.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The metabolites of lactic acid bacteria (LAB) and bifidobacteria (Bb) have recently received a lot of attention due to their ability to protect interactions in blood and tissues, as well as their biodegradability and biocompatibility in human tissue. Exopolysaccharides (EPS) derived from bacteria have a long history of use in therapeutic and other industrial applications with no adverse effects. In this regard, EPSs were isolated and characterized from LAB and Bb culture supernatants to determine their antioxidant, antitumor, and periodontal regeneration properties. The antioxidant capacity of the EPSs varied with concentration (0.625-20 mg/ml). The highest antioxidant activity was found in LAB:
DSM 24731-EPS
,
ssp.
DSM 20081
-EPS
,
DSM 20049-EPS
, and Bb;
ssp.
DSM 200707-EPS
. Human breast cancer cells (MCF7), human colon cancer cells (CaCo2), human liver cancer cells (HepG2), and human embryonic kidney 293 (HEK 293) cells were used as controls to assess the antitumor properties of the selected EPSs. According to the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromide (MTT) assay, EPS
had the highest cytotoxicity against MCF7, CaCo2, and HepG2, with IC
values of 7.91, 10.69, and 9.12 mg/ml, respectively. Lactate dehydrogenase (LDH) activity was significantly higher in cell lines treated with EPS
-IC
values compared to other EPSs-IC
values (
< 0.05). Real time (RT)-PCR results showed that EPS
treatment increased
,
,
, and
gene expression. The expression of the
,
, and
genes, on the other hand, was reduced. The MTT test was used to examine the effect of EPS
on the viability of human periodontal ligament fibroblast cells (hPDLFCs), and it was discovered that EPS
increased hPDLFC viability. According to high-performance liquid chromatography (HPLC) analysis, galactose made up 12.5% of EPS
. The findings of this study pave the way for the use of EPS, which hold great promise for a variety of therapeutic purposes such as antioxidant, antitumor, and periodontal regeneration. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Food Microbiology, a section of the journal Frontiers in Microbiology Edited by: Sabina Górska, Hirszfeld Institute of Immunology and Experimental Therapy (PAS), Poland Reviewed by: Junling Shi, Northwestern Polytechnical University, China; Babak Haghshenas, Kermanshah University of Medical Sciences, Iran |
ISSN: | 1664-302X 1664-302X |
DOI: | 10.3389/fmicb.2022.803688 |